✦ LIBER ✦

Expectant therapy for clinical stage A nonseminomatous germ-cell tumors of the testis? No

✍ Scribed by Gary Lieskovsky; Donald G. Skinner

Publisher: Springer-Verlag
Year: 1984
Tongue: English
Weight: 488 KB
Volume: 2
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf00326934

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expectant therapy for clinical stage A n

Expectant therapy for clinical stage A nonseminomatous germ-cell cancers of the testis? A qualified “Yes”

✍ Derek Raghavan 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 483 KB

Expectant therapy for clinical stage A n

Expectant therapy for clinical stage A nonseminomatous germ-cell tsticular cancer? Maybe

✍ M. A. S. Jewett; J. G. Herman; J. F. G. Sturgeon; R. H. Comisarow; R. E. Alison; 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 189 KB

Adjuvant chemotherapy for stage II nonse

Adjuvant chemotherapy for stage II nonseminomatous germ cell cancer of the testis

✍ B. J. Kennedy; Jane L. Torkelson; Elwin E. Fraley 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

Results of adjuvant chemotherapy for low

Results of adjuvant chemotherapy for low-stage nonseminomatous germ cell tumors of the testis with vascular invasion

✍ T. F. Sandeman; C. Yang 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Evolution and controversies in the manag

Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis

✍ G. Pizzocaro; N. Nicolai; R. Salvioni 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 814 KB

The indication for postchemotherapy lymp

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

✍ Atreya Dash; Brett S. Carver; Jason Stasi; Dean F. Bajorin; Robert J. Motzer; Ge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## BACKGROUND The initial management of patients with clinical stage IS (cIS) nonseminomatous germ cell tumor (NSGCT) has evolved from primary retroperitoneal lymph node dissection (RPLND) to induction chemotherapy. The objectives of the current study were to determine the clinical out